Abstract
Abstract
Deaths caused by respiratory failure and multiple organ dysfunction constitute a central difficulty in patients with COVID-19. Experts have recommended early chest computed tomography (CT) to detect suspicious patients. However, the high transmissibility rate of SARSCoV-2 and the risk of transporting unstable patients with hypoxemia and hemodynamic instability make chest CT a very limited option for the patient with suspected or confirmed COVID-19. Pulmonary ultrasound achieves early detection of abnormalities that facilitate clinical decision making, with results similar to chest CT and superior to standard chest radiography, in patients with pneumonia or Acute Respiratory Distress Syndrome (ARDS). Considering the recent reports on the findings of lung ultrasound of new SARS CoV-2 pneumonia and the experience of our working group, we have made recommendations on the usefulness of lung ultrasound in the management of these patients.
Key words: COVID-19; lung ultrasound; SARS CoV-2; Respiratory insufficiency; Acute Respiratory Distress Syndrome.
The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.
